Literature DB >> 21422433

On the usefulness of outcome-adaptive randomization.

Ying Yuan, Guosheng Yin.   

Abstract

Mesh：

Year:  2011        PMID： 21422433     DOI： 10.1200/JCO.2010.34.5330

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

1.  Statistical controversies in clinical research: scientific and ethical problems with adaptive randomization in comparative clinical trials.

Authors:  P Thall; P Fox; J Wathen
Journal:  Ann Oncol       Date:  2015-05-15       Impact factor: 32.976

2.  NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers.

Authors:  Yaacov Richard Lawrence; Bhadrasain Vikram; James J Dignam; Arnab Chakravarti; Mitchell Machtay; Boris Freidlin; Naoko Takebe; Walter J Curran; Soren M Bentzen; Paul Okunieff; C Norman Coleman; Adam P Dicker
Journal:  J Natl Cancer Inst       Date:  2012-12-10       Impact factor: 13.506

3.  Worth adapting? Revisiting the usefulness of outcome-adaptive randomization.

Authors:  J Jack Lee; Nan Chen; Guosheng Yin
Journal:  Clin Cancer Res       Date:  2012-07-02       Impact factor: 12.531

4.  Resist the Temptation of Response-Adaptive Randomization.

Authors:  Michael Proschan; Scott Evans
Journal:  Clin Infect Dis       Date:  2020-12-31       Impact factor: 9.079

5.  A simulation study of outcome adaptive randomization in multi-arm clinical trials.

Authors:  J Kyle Wathen; Peter F Thall
Journal:  Clin Trials       Date:  2017-02-01       Impact factor: 2.486

Review 6.  The Bayesian Design of Adaptive Clinical Trials.

Authors:  Alessandra Giovagnoli
Journal:  Int J Environ Res Public Health       Date:  2021-01-10       Impact factor: 3.390

Review 7.  Practical Considerations and Recommendations for Master Protocol Framework: Basket, Umbrella and Platform Trials.

Authors:  Chengxing Cindy Lu; Xiaoyun Nicole Li; Kristine Broglio; Paul Bycott; Qi Jiang; Xiaoming Li; Anna McGlothlin; Hong Tian; Jingjing Ye
Journal:  Ther Innov Regul Sci       Date:  2021-06-23       Impact factor: 1.778
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.